美敦力分拆，高管涨薪

CHC医疗传媒01-13

全球医疗器械巨头美敦力（NYSE:MDT）在推进糖尿病业务分拆计划的关键阶段，于向美国证券交易委员会提交的MiniMed S-1注册声明中完整披露了核心高管薪酬架构、运营数据及潜在风险。此次分拆预计2026年底前完成，同步启动首次公开募股（IPO），新公司将聚焦糖尿病综合管理，产品涵盖胰岛素泵、连续血糖监测仪（CGM）及配套软件服务。#01财务与运营核心数据美敦力2025财年（截至2025年4月...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2603659205?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-13 15:10","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2603659205","market":"us","top_or_hot":-1,"title":"美敦力分拆，高管涨薪","media":"CHC医疗传媒","content":"<div>\n<p>全球医疗器械巨头美敦力（NYSE:MDT）在推进糖尿病业务分拆计划的关键阶段，于向美国证券交易委员会提交的MiniMed S-1注册声明中完整披露了核心高管薪酬架构、运营数据及潜在风险。此次分拆预计2026年底前完成，同步启动首次公开募股（IPO），新公司将聚焦糖尿病综合管理，产品涵盖胰岛素泵、连续血糖监测仪（CGM）及配套软件服务。#01财务与运营核心数据美敦力2025财年（截至2025年4月...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011315275197a1945d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美敦力分拆，高管涨薪</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美敦力分拆，高管涨薪\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-13 15:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011315275197a1945d&s=b><strong>CHC医疗传媒</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>全球医疗器械巨头美敦力（NYSE:MDT）在推进糖尿病业务分拆计划的关键阶段，于向美国证券交易委员会提交的MiniMed S-1注册声明中完整披露了核心高管薪酬架构、运营数据及潜在风险。此次分拆预计2026年底前完成，同步启动首次公开募股（IPO），新公司将聚焦糖尿病综合管理，产品涵盖胰岛素泵、连续血糖监测仪（CGM）及配套软件服务。#01财务与运营核心数据美敦力2025财年（截至2025年4月...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011315275197a1945d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0211331839.USD","symbol_name":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011315275197a1945d&s=b","article_id":"2603659205","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011315275197a1945d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2603659205","pubTimestamp":1768288227,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"全球医疗器械巨头美敦力在推进糖尿病业务分拆计划的关键阶段，于向美国证券交易委员会提交的MiniMed S-1注册声明中完整披露了核心高管薪酬架构、运营数据及潜在风险。另外，美敦力披露Simpra CGM制造环节存在重大问题，预计产生1亿至1.2亿美元税前费用，涉及合同终止、资产减销及生产线退出成本。美敦力强调，此次披露严格遵循SEC IPO企业信息披露要求，完整细节已载入S-1注册声明。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","BK4566":"资本集团","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","IE00B42XCP33.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) INC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","MDT":"美敦力","BK4588":"碎股","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","IE00BQXX3C00.GBP":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","IE00BQXX3F31.USD":"GUINNESS GLOBAL INNOVATORS \"C\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","IE00BVYPNW00.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK4585":"ETF&股票定投概念"},"translate_title":"Medtronic spin-off, executives raise pay","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1.5},"content_text":"全球医疗器械巨头美敦力（NYSE:MDT）在推进糖尿病业务分拆计划的关键阶段，于向美国证券交易委员会提交的MiniMed S-1注册声明中完整披露了核心高管薪酬架构、运营数据及潜在风险。此次分拆预计2026年底前完成，同步启动首次公开募股（IPO），新公司将聚焦糖尿病综合管理，产品涵盖胰岛素泵、连续血糖监测仪（CGM）及配套软件服务。#01财务与运营核心数据美敦力2025财年（截至2025年4月25日）总营收336.3亿美元，糖尿病业务销售额27.5亿美元，占比8%。该业务2025财年营收同比增长10.7%，但仅贡献公司分部营业利润的4%。新公司总部设于加州北岭，拥有8000余名员工，胰岛素泵用户超64万，2025年10月CGM搭载率65%，体现持续销售模式稳定性。分拆后，美敦力预计整体调整后毛利率将提升50个基点，营业利润率提升100个基点。截至2025年10月24日的六个月，MiniMed净销售额14.8亿美元，净亏损2100万美元，较去年同期13.0亿美元销售额和2300万美元亏损有所改善，CGM搭载率达65%，83%收入来自CGM、耗材、软件及服务。另外，美敦力披露Simpra CGM制造环节存在重大问题，预计产生1亿至1.2亿美元税前费用，涉及合同终止、资产减销及生产线退出成本。管理层已批准2025年12月终止第三方制造协议的计划，供应商身份未披露。#02高管薪酬及遣散全景披露五位核心高管2025财年直接薪酬总额超1420万美元，分拆后薪酬显著提升：Que Dallara（MiniMed首席执行官）：2025财年薪酬850万美元，含758,269美元薪资、470万美元股票奖励、180万美元期权奖励、782,595美元现金绩效薪酬及382,787美元其他补偿（含24.5万美元搬迁费、6.7万美元安保服务）。分拆后总直接薪酬预计达1020万美元，增幅超20%。Ali Dianaty（产品创新与运营高级副总裁）：2025财年薪酬250万美元，含574,943美元薪资、140万美元股票奖励、25,002美元期权奖金及340,481美元现金奖金，其他补偿66,008美元。分拆后激励目标总额超310万美元。Gillian Chandrasena（首席人力资源官）：2025财年薪酬180万美元，含80,096美元薪资、170万美元新员工股票奖励及34,381美元现金奖金，其他补偿4,904美元。分拆后激励目标超150万美元。Courtney Nelson Wills（首席公司治理与证券法律顾问）：2025财年薪酬120万美元，含442,254美元薪资、441,201美元股票奖励、25,002美元期权奖励及245,461美元现金奖金，其他补偿54,560美元。分拆后激励目标超190万美元。Chad Spooner（首席财务官）：2025年7月加入，薪酬总额370万美元，含140万美元新员工现金奖金及230万美元限制性股票单位奖励，目标条款匹配前雇主未兑现权益。文件详细披露控制权变更或非自愿解雇场景下的遣散安排：Dallara：非自愿解雇可获270万美元（含230万美元遣散费、5.1万美元福利及36.6万美元股权延续）；控制权变更后解雇可获近1590万美元（含430万美元遣散费、750万美元绩效股加速归属及340万美元限制性股票加速归属）。Dianaty、Chandrasena及Nelson Wills：非自愿解雇分别可获160万、120万及44.7万美元；控制权变更后解雇分别可获420万、180万及150万美元。MiniMed尚未成立独立薪酬委员会，安永协助选定九家直接竞争对手作为薪酬对比基准：Dexcom、Masimo、Exact Sciences、ResMed、Hologic、Tandem Diabetes Care、Insulet、Teleflex及Intuitive Surgical，选择标准为医疗/工业/IT行业规模相近的上市公司。美敦力强调，此次披露严格遵循SEC IPO企业信息披露要求，完整细节已载入S-1注册声明。MiniMed IPO承销商包括高盛、美银证券、花旗及摩根士丹利，募资将用于偿还美敦力债务及业务扩展。此次分拆标志着美敦力战略重组的重要一步，通过聚焦心血管、神经科学等高利润核心业务，优化业务组合以实现长期增长目标。以上如有信息误差或侵权问题，欢迎联系作者处理删除，谢谢！","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603659205","isCrawlerRequest":true}